Antiepileptic Drugs and Osteoporotic Prevention Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

January 31, 2013

Conditions
EpilepsyBone LossOsteoporosisFractures
Interventions
DRUG

Risedronate

35 mgs/week + calcium and vit d

DRUG

Placebo + Calcium and Vitamin D

sugar pill + calcium 1200mgs/day and vitamin d at least 800IU

Trial Locations (1)

02130

VA Boston Healthcare System, Boston

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

collaborator

Alliance for Better Bone Health

OTHER

collaborator

VA Boston Healthcare System

FED

lead

Boston VA Research Institute, Inc.

OTHER

NCT00869622 - Antiepileptic Drugs and Osteoporotic Prevention Trial | Biotech Hunter | Biotech Hunter